IP Library Granted Patent US 8,357,139
Granted Patent B2
US 8,357,139 · App. 12/264,849 · Granted Jan 22, 2013

Methods and devices for use in performing pulmonary procedures

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,357,139
App. No.
12/264,849
Granted
Jan 22, 2013
Kind
B2
Abstract

Systems, methods and devices for performing pulmonary procedures, and in particular treating lung disease. A flow control element includes a valve that prevents airflow in the inhalation direction but permits airflow in the exhalation direction. The flow control element is guided to and positioned at the site by a bronchoscope that is introduced into the patient's trachea and used to view the lungs during delivery of the flow control element. The valve may include one, two or more valve elements, and it may be collapsible for easier delivery. A source of vacuum or suction may be used to increase the amount of fluid withdrawn from the lung tissue. A device for measuring hollow structures, such as bronchioles, and a device for removing a previously-placed flow control element are disclosed as well.

Claims (8)

1. A method for treating a diseased portion of a lung in a patient, the method comprising:

measuring a lung passageway leading to the diseased portion of the lung;

introducing a therapeutic substance into the diseased portion of the lung, wherein the therapeutic substance is capable of repairing lung tissue; and

delivering an implantable flow control element to an airway of the patient's respiratory system leading to the diseased portion of the lung to reduce fluid flow out of the diseased portion.

2. A method as in claim 1 , wherein the therapeutic substance is introduced into the portion of the lung via a bronchoscope.

3. A method as in claim 2 , wherein the substance is introduced and the implantable flow control element is delivered via a working channel in the bronchoscope.

4. A method as in claim 1 , wherein the introduced therapeutic substance is selected from the group consisting of an anti-angiogenesis factor, an antibiotic, an anti-inflammatory agent, a sclerosing agent, an agent that absorbs fluid and a sealing substance.

5. A method as in claim 1 , wherein the implantable flow control element restricts fluid flow in a first, inhalation direction and reduces fluid flow in a second, exhalation direction.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2010
From: DEEM, MARK E.; GIFFORD, HANSON S., III; FRENCH, RONALD; SUTTON, DOUGLAS
To: THE FOUNDRY
Reel/Frame 023874/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2010
From: THE FOUNDRY, LLC
To: EMPHASYS MEDICAL, INC.
Reel/Frame 023874/0800 →